GlassScriptPhysician profile
Anushareddy Muddasani
NPI 1760919872
$735.24
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $489 · 2022: $160 · 2023: $56.45 · 2024: $29.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $124.47 | 2021 | |
| Amgen INC. | $98.30 | 2021-2023 | Otezla, Repatha, Evenity |
| Pfizer INC. | $73.81 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $54.76 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.85 | 2021 | |
| Boston Scientific Corporation | $41.95 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Astrazeneca Pharmaceuticals LP | $36.29 | 2021 | |
| Horizon Therapeutics Plc | $30.72 | 2021 | |
| Abbvie INC. | $28.61 | 2021 | |
| Janssen Pharmaceuticals, INC | $27.66 | 2021-2022 | |
| Novo Nordisk INC | $25.43 | 2022-2023 | Rybelsus, Ozempic |
| Amarin Pharma, INC. | $24.54 | 2021 | |
| Glaxosmithkline, LLC. | $20.10 | 2022 | |
| Nestle Healthcare Nutrition INC. | $16.78 | 2021 | |
| Esperion Therapeutics, INC. | $16.38 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $15.98 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.27 | 2022 | |
| Currax Pharmaceuticals LLC | $14.14 | 2021 | |
| Medtronic, INC. | $13.62 | 2021 | |
| Lilly USA, LLC | $12.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anushareddy Muddasani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.